| December 10, 2001 |
December 10, 2001
Cerus and Baxter Report Results in Trial of INTERCEPT Red Blood Cell System
|
| December 10, 2001 |
December 10, 2001
Cerus and Baxter Present Phase III Results for the INTERCEPT Platelet and Plasma Systems At the American Society of Hematology Meeting
|
| December 10, 2001 |
December 10, 2001
Cerus and Baxter Report Results in Trial of INTERCEPT Red Blood Cell System; Companies Reach Agreement with FDA on Pivotal Phase III Protocol
|
| November 15, 2001 |
November 15, 2001
Cerus Corporation Names Bruce Cozadd to Board of Directors
|
| October 23, 2001 |
October 23, 2001
Cerus Corporation Announces Third Quarter Results
|
| October 17, 2001 |
October 17, 2001
Cerus and Baxter Report Positive Results in Trial of INTERCEPT Red Blood Cells
|
| October 15, 2001 |
October 15, 2001
Cerus and Baxter Report Inactivation of Trypanosoma Cruzi Parasite; Data Demonstrates That Helinx Technology Inactivates Deadly Parasite Known to Cause Chagas Disease
|
| October 4, 2001 |
October 4, 2001
Cerus Corporation Appoints David N. Cook as Vice President, Biotherapeutic Research and Development
|
| August 17, 2001 |
August 17, 2001
Cerus and Baxter Report Primary Endpoint Met in U.S. Phase III Trial of the INTERCEPT Plasma System
|
| August 17, 2001 |
August 17, 2001
Cerus and Baxter Report Primary Endpoint Met in U.S. Phase III Trial of the INTERCEPT Plasma System; Data Support Submission for U.S. Regulatory Approval
|
| August 10, 2001 |
August 10, 2001
Cerus Corporation Files Shelf Registration Statement
|
| July 26, 2001 |
July 26, 2001
Cerus Corporation Announces the Death of Dale A. Smith
|
| July 24, 2001 |
July 24, 2001
Cerus Corporation Announces Second Quarter Results
|
| July 21, 2001 |
July 21, 2001
Cerus Corporation Invites You to Join a Webcast of its Second Quarter Conference Call
|
| July 16, 2001 |
July 16, 2001
Cerus and Baxter Report Additional INTERCEPT Platelet Data From European Phase III Trial
|
| June 12, 2001 |
June 12, 2001
Cerus Receives Discover Magazine Innovation Award
|
| May 17, 2001 |
May 17, 2001
Cerus Announces Private Placements Totaling $78 Million
|
| April 24, 2001 |
April 24, 2001
Cerus Corporation Announces First Quarter Results
|
| March 7, 2001 |
March 7, 2001
Cerus Corporation Receives $3.5 Million Award to Improve Safety of Blood Supply for U.S. Armed Forces
|
| February 20, 2001 |
February 20, 2001
Cerus Corportation Names Vice President of Marketing
|
| January 25, 2001 |
January 25, 2001
Cerus and Baxter Complete Enrollment in U.S. Phase III Trial of Intercept Platelet System
|
| January 25, 2001 |
January 25, 2001
Cerus Corporation Announces Fourth Quarter and Year-end Results
|
| January 23, 2001 |
January 23, 2001
Cerus Corporation Receives Broad U.S. Patent Covering Pathogen Inactivation in Blood
|
| January 2, 2001 |
January 2, 2001
Cerus and Baxter Submit CE Mark Application for European Approval of the Intercept Platelet System
|